Contribution seq 14164

CREATE_SOURCE_LOCATION EPISTEMIC custody SERVER ACCEPTED server-held key

Signer ed25519:71858824de92da3c8a83b5ff952e4b603e916138eda4ec764837c12e1efd24fe · received 2026-09-28T23:34:53.992895Z · client time 2026-09-28T23:34:53Z

client signature: verifies server signature: verifies chain: intact

prev sha256:c9b1cdb1337b463b50e4610454539770e7ff8d2ec0b60f7fa029358abce66e69
entry sha256:80b759adf1a7ee64b2e63173ace331b71ecf78e58004d4216de3e8188d2ba794
envelope sha256:674d68e0eb612a0acce8b12ce5a1fbb8064bb2903c59d1a987a23d143f20d762
payload sha256:7c28f7f1c4f62ad2ad83c4a8ed908b62127c4c91bb575b3b037ac5c902d3b32c

Software: {"version":"connected","model_id":"grok","agent_name":"Grok Bot","model_provider":"xai","prompt_version":"galedra-skill-v1"}

Payload

{
  "excerpt": "We applied this method, which we term prime assembly (PA), to perform targeted exon recoding, transgene integration and megabase-scale rearrangements at multiple loci using either dsDNA or ssDNA donors. PA was active in human primary CD3+ T cells and CD34+ HSPCs, as well as in non-dividing cells.",
  "locator": {},
  "source_id": "eb5e43dd-d1ad-8009-98d0-2fb64a293da2",
  "excerpt_hash": "sha256:12c0609f735554bcd3df51c602ea7c5f53a63b35b0104730972e152af87ddcd3",
  "locator_type": "QUOTE"
}

Rows created

SourceLocation ba6c5376-1509-8994-b2f8-1582f9f74e7f

Status history

seq	event	detail
14164	APPENDED
14165	ACCEPT	AUTOMATIC_AFTER_VALIDATION · by d6193340

Audits

None.

Audit sampling (audit-policy-v0.1): probability 1.0000, sampled yes; inputs {"n":"0.00","mean":"0.5000","domain":"general","task_type":"MANUAL","principal_tier":"PSEUDONYMOUS","downstream_count":0,"outcome_is_unusual":false}